BioInno Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 13

BioInno General Information

Description

Provider of CDMO process development and GMP production services for cell culture, bioprocessing, and biologics-related technical applications. The company offers outsourcing services, specializing in developing cell therapy and gene therapy drugs for biotechnology and pharmaceutical companies.

Contact Information

Website
www.bioinnobio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Beijing Yizhuang Economic Development Zone
  • Beijing, 100101
  • China
+86 0512
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Beijing Yizhuang Economic Development Zone
  • Beijing, 100101
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioInno Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 03-Dec-2025 Completed Generating Revenue
3. Early Stage VC (Series A) 02-Dec-2021 Completed Generating Revenue
2. Early Stage VC 09-Feb-2021 $15.4M $16.9M Completed Generating Revenue
1. Seed Round 01-Jul-2020 $1.41M $1.41M Completed Startup
To view BioInno’s complete valuation and funding history, request access »

BioInno Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioInno Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shenzhen Zhuojia Huizhi Venture Capital Venture Capital Minority
Ao Peng Investment PE/Buyout Minority
BridgeOne Capital Venture Capital Minority
Ciit Asset Management Asset Manager Minority
Hangzhou Tailong Venture Capital Partnership Growth/Expansion Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

BioInno FAQs

  • When was BioInno founded?

    BioInno was founded in 2019.

  • Where is BioInno headquartered?

    BioInno is headquartered in Beijing, China.

  • What is the size of BioInno?

    BioInno has 4 total employees.

  • What industry is BioInno in?

    BioInno’s primary industry is Pharmaceuticals.

  • Is BioInno a private or public company?

    BioInno is a Private company.

  • What is BioInno’s current revenue?

    The current revenue for BioInno is .

  • How much funding has BioInno raised over time?

    BioInno has raised $48.1M.

  • Who are BioInno’s investors?

    Shenzhen Zhuojia Huizhi Venture Capital, Ao Peng Investment, BridgeOne Capital, Ciit Asset Management, and Hangzhou Tailong Venture Capital Partnership are 5 of 13 investors who have invested in BioInno.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process